中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

IARS1单杂合突变相关生长迟缓和肝病1例报告

李阳 毛迪 魏丽亚 巩纯秀

引用本文:
Citation:

IARS1单杂合突变相关生长迟缓和肝病1例报告

DOI: 10.12449/JCH250419
伦理学声明:本例报告已获得患儿家属知情同意。
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:李阳负责课题设计,资料收集和分析,撰写和修改论文;毛迪负责资料分析和修改论文;魏丽亚负责资料收集;巩纯秀负责拟定写作思路,指导撰写文章并最后定稿。
详细信息
    通信作者:

    巩纯秀, chunxiugong@163.com (ORCID: 0000-0002-1262-7383)

Growth retardation and hepatopathy associated with single heterozygous mutations in the IARS1 gene: A case report

More Information
  • 摘要: IARS1基因变异罕见,经检索,仅有10例详尽临床及遗传数据的病例被文献报道。本文报道了1例IARS1单杂合变异相关的生长迟缓和肝病,并总结IARS1变异导致生长迟缓、智力障碍、肌张力低下和肝病的临床及遗传学特点,扩展了生长迟缓、智力障碍、肌张力低下和肝病的遗传谱。

     

  • 注: a,患儿IARS1基因c.2354del杂合变异,父亲杂合变异,母亲该位点无变异;b,患儿APOB基因c.2963A>C杂合变异,父亲该位点无变异,母亲杂合变异;c,变异蛋白与野生型蛋白三维结构

    图  1  患儿突变位点Sanger测序及生物信息学分析

    Figure  1.  Sanger sequencing and bioinformatics analysis of the mutation site in the patient

    注: a,4岁5个月面容;b,6岁2个月面容;c,4岁5个月骨龄;d,6岁2个月骨龄;e,GH治疗生长曲线。

    图  2  患儿临床特征

    Figure  2.  Clinical features of the patient

    表  1  患儿GH治疗前后体格生长和生化指标变化

    Table  1.   Changes in physical growth and biochemical parameters before and after GH treatment in patient

    年龄 身高(cm) HAZ 体质量(kg) WAZ

    ALT

    (U/L)

    AST

    (U/L)

    TC

    (mmol/L)

    LDL-C (mmol/L) IGF-1 (ng/mL) IGFBP3 (μg/mL)
    6个月 59.0 -3.53 6.4 -1.81
    1岁4个月 69.0 -3.94 8.1 -2.32 44.0
    4岁5个月 94.0 -3.15 13.5 -2.09
    4岁7个月 94.0 -3.38 13.6 -2.18 35.6 46.5 6.57 31.8 2.33
    4岁11个月 97.9 -2.88 14.3 -2.03 48.9 38.9 38.4 2.17
    5岁2个月 101.5 -2.35 15.4 -1.60 53.2 49.2 5.75 3.41 69.7 4.62
    5岁5个月 104.2 -2.07 15.4 -1.82 54.0 56.0 4.44 2.81 48.3 3.31
    5岁8个月 106.5 -1.87 17.2 -1.10 53.9 56.9 4.98 3.12 62.1 3.23
    6岁2个月 110.7 -1.53 18.0 -1.12 39.3 39.7 4.61 2.55 114.0 4.59

    注:HAZ,身高标准差分值;WAZ,体质量标准差分值。

    下载: 导出CSV
  • [1] HYUN SE, LEE BC, SUH BK, et al. Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents[J]. Clin Biochem, 2012, 45( 1-2): 16- 21. DOI: 10.1016/j.clinbiochem.2011.10.003.
    [2] RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17( 5): 405- 424. DOI: 10.1038/gim.2015.30.
    [3] KOPAJTICH R, MURAYAMA K, JANECKE AR, et al. Biallelic IARS mutations cause growth retardation with prenatal onset, intellectual disability, muscular hypotonia, and infantile hepatopathy[J]. Am J Hum Genet, 2016, 99( 2): 414- 422. DOI: 10.1016/j.ajhg.2016.05.027.
    [4] ORENSTEIN N, WEISS K, OPRESCU SN, et al. Bi-allelic IARS mutations in a child with intra-uterine growth retardation, neonatal cholestasis, and mild developmental delay[J]. Clin Genet, 2017, 91( 6): 913- 917. DOI: 10.1111/cge.12930.
    [5] SMIGIEL R, BIELA M, BIERNACKA A, et al. New evidence for association of recessive IARS gene mutations with hepatopathy, hypotonia, intellectual disability and growth retardation[J]. Clin Genet, 2017, 92( 6): 671- 673. DOI: 10.1111/cge.13080.
    [6] FUCHS SA, SCHENE IF, KOK G, et al. Aminoacyl-tRNA synthetase deficiencies in search of common themes[J]. Genet Med, 2019, 21( 2): 319- 330. DOI: 10.1038/s41436-018-0048-y.
    [7] WANG GJ, REYILANMU BEH, DILIHUMA JLT, et al. A case of GRIDHH caused by IARS gene mutation[J]. Chin J Birth Health Heredity, 2021, 29( 1): 94- 95.

    王国杰, 热衣兰木·包尔汉, 迪丽胡麻·居来提, 等. IARS基因突变导致的GRIDHH一例[J]. 中国优生与遗传杂志, 2021, 29( 1): 94- 95.
    [8] ZOU TT, SUN HQ, ZHU Y, et al. Compound heterozygous variations in IARS1 cause recurrent liver failure and growth retardation in a Chinese patient: A case report[J]. BMC Pediatr, 2022, 22( 1): 329. DOI: 10.1186/s12887-022-03371-6.
    [9] JIANG JS, FENG Y, TANG QY, et al. Novel IARS1 variants cause syndromic developmental disorder with epilepsy in a Chinese patient and the literature review[J]. Mol Genet Genomic Med, 2024, 12( 1): e2326. DOI: 10.1002/mgg3.2326.
    [10] WATANABE M, SHISHIDO K, KANEHIRA N, et al. Molecular and pathological analyses of IARS1-deficient mice: An IARS disorder model[J]. Int J Mol Sci, 2023, 24( 8): 6955. DOI: 10.3390/ijms24086955.
    [11] WHITFIELD AJ, BARRETT PH, VAN BOCKXMEER FM, et al. Lipid disorders and mutations in the APOB gene[J]. Clin Chem, 2004, 50( 10): 1725- 1732. DOI: 10.1373/clinchem.2004.038026.
    [12] YAN J. Progress of diagnosis and treatment in children with short stature[J]. Chin J Appl Clin Pediatr, 2016, 31( 23): 1778- 1782. DOI: 10.3760/cma.j.issn.2095-428X.2016.23.005.

    闫洁. 儿童矮身材诊治进展[J]. 中华实用儿科临床杂志, 2016, 31( 23): 1778- 1782. DOI: 10.3760/cma.j.issn.2095-428X.2016.23.005.
  • 加载中
图(2) / 表(1)
计量
  • 文章访问数:  113
  • HTML全文浏览量:  39
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-10-02
  • 录用日期:  2024-11-25
  • 出版日期:  2025-04-25
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回